Can probiotics change fish behavior?


Frank and her colleagues in Christina Semeniuk’s lab and comentor Daniel Heath’s lab at the University of Windsor in Ontario are trying to determine whether an unlikely intervention — a probiotic supplement in fish food — might help triploid Chinook salmon fare better. They’re starting with how the fish behave.
“Behavioral flexibility and sensitivity … would be an immediate measure for physiological (and neural genomic) change, given the connections between the gut–brain–behavior axis,” Semeniuk said.
Frank tested how probiotic supplements added to fish food affected the way hundreds of fingerling diploid and triploid fish respond to novel stimuli such as a glass bead tossed into the tank, a predator-shaped dummy passing overhead and an approaching human researcher. She will present her work as part of the Genomics poster session during the 2021 ASBMB annual meeting; you can see her talk and post questions while the meeting is underway.
In the future, Frank plans to integrate transcriptomic analyses with her behavioral studies, an approach known as behavioral genomics. Little is known about how triploidy affects genes related to learning and memory, so even if probiotics have little effect, she stands to learn something interesting.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Training AI to uncover novel antimicrobials
Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.

Antibiotic sensor directly binds drug in resistant bacteria
Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.

ApoA1 reduce atherosclerotic plaques via cell death pathway
Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.

Omega-3 lowers inflammation, blood pressure in obese adults
A randomized study shows omega-3 supplements reduce proinflammatory chemokines and lower blood pressure in obese adults, furthering the understanding of how to modulate cardiovascular disease risk.